# Investigating the long-term public health and co-benefit impacts of an urban greenway intervention in the UK: a natural experiment evaluation – study protocol

**Authors:** Ruth F Hunter, Claire Cleland, Ruoyu Wang, Ciaran O’Neill, Shay Mullineaux, Christopher Tate, Hüseyin Küçükali, Selin Akaraci, Niamh O’Kane, Leandro Garcia, Mike Clarke, Christopher R Cardwell, Sophie Jones, Aideen Maguire, Geraint Ellis, Brendan Murtagh, Anna Jurek-Loughrey, Dominic Bryan, John Barry, Jeremy Hilton, Mehdi Hafezi, Natalie Clewley, Frank Kee

PMC · DOI: 10.1136/bmjopen-2024-097530 · 2025-07-06

## TL;DR

This study evaluates the public health and co-benefits of an urban greenway in Belfast over 5 years using surveys, administrative data, and stakeholder engagement.

## Contribution

This is one of the first natural experiments with a 5-year follow-up to assess urban green space interventions' long-term impacts.

## Key findings

- Uses mixed methods including surveys and administrative data to evaluate health and co-benefits of urban greenways.
- Incorporates stakeholder engagement and systems modeling to understand intervention impacts and pathways.
- Aims to inform future policy on urban green space interventions through comprehensive evaluation.

## Abstract

Urban green and blue space (UGBS) interventions, such as the development of an urban greenway, have the potential to provide public health benefits and multiple co-benefits in the realms of the environment, economy and society. This paper presents the protocol for a 5-year follow-up evaluation of the public health benefits and co-benefits of an urban greenway in Belfast, UK.

The natural experiment evaluation uses a range of systems-oriented and mixed-method approaches. First, using group model building methods, we codeveloped a causal loop diagram with stakeholders to inform the evaluation framework. We will use other systems methods including viable systems modelling and soft systems methodology to understand the context of the system (ie, the intervention) and the stakeholders involved in the development, implementation and maintenance phases. The effectiveness evaluation includes a repeat cross-sectional household survey with a random sample of 1200 local residents (adults aged ≥16 years old) who live within 1 mile of the greenway. The survey is complemented with administrative data from the National Health Service. For the household survey, outcomes include physical activity, mental well-being, quality of life, social capital, perceptions of environment and biodiversity. From the administrative data, outcomes include prescription medications for a range of non-communicable diseases such as cardiovascular disease, type II diabetes mellitus, chronic respiratory and mental health conditions. We also investigate changes in infectious disease rates, including COVID-19, and maternal and child health outcomes such as birth weight and gestational diabetes. A range of economic evaluation methods, including a cost-effectiveness analysis and social return on investment (SROI), will be employed. Findings from the household survey and administrative data analysis will be further explored in focus groups with a subsample of those who complete the household survey and the local community to explore possible mechanistic pathways and other impacts beyond those measured. Process evaluation methods include intercept surveys and direct observation of the number and type of greenway visitors using the Systems for Observing Play and Recreation in Communities tool. Finally, we will use methods such as weight of evidence, simulation and group model building, each embedding participatory engagement with stakeholders to help us interpret, triangulate and synthesise the findings.

To our knowledge, this is one of the first natural experiments with a 5-year follow-up evaluation of an UGBS intervention. The findings will help inform future policy and practice on UGBS interventions intended to bring a range of public health benefits and co-benefits. Ethics approval was obtained from the Medicine, Health and Life Sciences Research Ethics Committee prior to the commencement of the study. All participants in the household survey and focus group workshops will provide written informed consent before taking part in the study. Findings will be reported to (1) participants and stakeholders; (2) funding bodies supporting the research; (3) local, regional and national governments to inform policy; (4) presented at local, national and international conferences and (5) disseminated by peer-review publications.

## Linked entities

- **Diseases:** cardiovascular disease (MONDO:0004995), type II diabetes mellitus (MONDO:0005148), infectious disease (MONDO:0005550), COVID-19 (MONDO:0100096), gestational diabetes (MONDO:0005406)

## Full-text entities

- **Diseases:** COVID-19 (MESH:D000086382), infectious disease (MESH:D003141), gestational diabetes (MESH:D016640), cardiovascular disease (MESH:D002318), type II diabetes mellitus (MESH:D003924)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12230955/full.md

---
Source: https://tomesphere.com/paper/PMC12230955